Literature DB >> 15226353

Gefitinib in recurrent glioblastoma.

M Raphael Pfeffer, Mark L Levitt, Dan Aderka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15226353     DOI： 10.1200/JCO.2004.99.299

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  EGF as a New Therapeutic Target for Medulloblastoma Metastasis.

Authors:  Jennifer Rico-Varela; Tanya Singh; Sean McCutcheon; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2015-06-04       Impact factor: 2.321

3.  RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Authors:  Arnab Chakravarti; Meihua Wang; H Ian Robins; Tim Lautenschlaeger; Walter J Curran; David G Brachman; Christopher J Schultz; Ali Choucair; Marisa Dolled-Filhart; Jason Christiansen; Mark Gustavson; Annette Molinaro; Paul Mischel; Adam P Dicker; Markus Bredel; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-22       Impact factor: 7.038
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.